Product code DKE— Clinical Toxicology

ACCUSIGN DOA 8, ACCUSIGN DOA 8 PANEL, ACCUSIGN THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA 8, BIOSIGN THC/OPI/COC/AMP/P

Classification name
Reagents, Test, Tetrahydrocannabinol
Device class
Class 2
Regulation
21 CFR 862.3870
Advisory panel
Clinical Toxicology
Total cleared
12
First cleared
Most recent

Market context for product code DKE

FDA has cleared 12 devices under product code DKE between 1980 and 2000, filed by 7 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code DKE

Recent clearances under product code DKE

Data sourced from openFDA. This site is unofficial and independent of the FDA.